Efficacy of rescue thrombolysis in patients with acute myocardial infarction: Preliminary findings

Cardiovascular Drugs and Therapy

Volumn 14, Issue 1, 2000, Pages 83-89

  Sarullo, Filippo Maria ^a   Americo, Luigi ^a   Di Pasquale, Pietro ^a,c   Castello, Antonio ^a   Mauri, Francesco ^b  

^a Division of Cardiology   (Italy)

^b A MANZONI HOSPITAL   (Italy)

^c Division of Cardiology Paolo Borsellino   (Italy)

Author keywords

Acute myocardial infarction; Rescue thrombolysis; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; CREATINE KINASE MB; HEPARIN; METOPROLOL;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REPERFUSION; SEX; SMOKING; ST SEGMENT ELEVATION; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; AGED; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0034050418     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007803523966     Document Type: Article

References (38)

1. 1. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-102.
2. 2. ISAM (Intravenous Streptokinase in Acute Myocardial Infarction) Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity and infarct size at 21 days. N Engl J Med 1986;314:1465-1471.
3. 3. AIMS (APSAC Intervention Mortality Study) Trial Study Group. Effects of intravenous APSAC in mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;1:545-549.
4. 4. ISIS 2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS - 2. Lancet 1988; 2:349-360.
5. 5. GISSI 2 (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
6. 6. ISIS 3 (Third International Study of Infarct Survival) Collaborative Group. A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and oral aspirin plus heparin alone in 41,299 cases of acute myocardial infarction. Lancet 1992;339:753-770.
7. 7. GUSTO Investigator. An international randomised trail comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
8. 8. Mauri F, Gasparini M, Barbonaglia L, et al. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI Trial). Am J Cardiol 1989;63:1291-1295.
9. 9. Stone GW, Grines CL, Browne KF, et al. Predictor of in-hospital and 6 month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995;25: 370-377.
10. 10. The CORAMI Study Group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am J Cardiol 1994;74:172-174.
11. 11. Di Pasquale P, Bucca V, Giuliano P, et al. Advantages of immediate two-dimensional echocardiography in patients with acute cardiac ischemic events. Int J Cardiol 1995;51: 85-91.
12. 12. Mauri F, Maggioni AP, Franzosi MG, et al. A simple electrocardiographie predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSi - 2) - Derived Analysis. J Am Coll Cardiol 1994;24:600-607.
13. 13. Hohnloser SH, Zabel M, Kasper W, et al. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18:44-49.
14. 14. Simoons ML, Arnold AER. Tailored thrombolytic therapy: a perspective. Circulation 1993;88:2556-2564.
15. 15. Zabel M, Hohnloser SH, Koster W, et al. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87:1542-1550.
16. 16. Krucoff MW, Croll MA, Pope JE, et al. Continuous 12-lead ST-segment recovery: analysis in the TAMI 7 Study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation 1993;88:437-446.
17. 17. Puleo PR, Perryman MB. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms. J Am Coll Cardiol 1991; 17:1047-1052.
18. 18. Zehender M, Utzolino S, Furtwangler A, et al. Time couse and interrelation of reperfusion-induced ST change and ventricular arrhythmias in acute myocardial infarction. Am J Cardiol 1991;68:1138-1142.
19. 19. Gressin V, Gorgels A, Louvard Y, et al. ST segment normalization time and ventricular arrhythmias as electrocardiographic markers of reperfusion during intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 1993; 71:1436-1439.
20. 20. Shah PK, Cercek B, Lew AS, et al. Angiographic validation of bedside markers of reperfusion. Am J Cardiol 1993,21: 55-61.
21. 21. Christian TF, Gibbons RJ, Hopfenspringer MR, et al. Severity and response of chest pain during thrombolytic theraphy for acute myocardial infarction: a useful indicator of myocardial salvage and infarct size. J Am Coll Cardiol 1993;22: 1311-1316.
22. 22. American Society of Echocardiography Committee on Standards. Subcommittee on quantitation of two-dimensional echocardiograms: recommendations for quantitation of left ventricle by two-dimensional echocardiography. J Am Soc Echo 1989;2:358-367.
23. 23. Neuhaus KL, von Essen R, Tebbe U, et al. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS). J Am Coll Cardiol 1992;19:885-891.
24. 24. Lange RA, Cigarroa RG, Hillis LD. Influence of residual anterograde coronary blood flow on survival after myocardial infarction in patients with multivessel coronary artery disease. Coronary Artery Dis 1990;1:59-63.
25. 25. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol 1989;64: 155-160.
26. 26. Rutherford JD, Pfeffer MA, Moye LA, et al. Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular Enlargement trial-SAVE Investigators. Circulation 1994;90:1731-1738.
27. 27. Abbottsmith CW, Topol EJ, George BS, et al. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achivied with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 1990;16:770-778.
28. 28. Ellis SG. Fatal outcome after unsuccessful "rescue angioplasty": cause or effect? J Interven Cardiol 1990;3:209-211.
29. 29. Ellis SG, Van de Werf F, Ribeiro-daSilva E, Topol EJ. Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials. J Am Coll Cardiol 1992;19:681-686.
30. 30. Mounsey JP, Skinner JS, Hawking T, et al. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction. Br Heart J 1995;74:348-353.
31. 31. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-627.
32. 32. Barbash GI, Hanoch H, Roth A, et al. Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia. J Am Coll Cardiol 1990;16:779-783.
33. 33. Simoons ML, Arnout J, van den Brand M, et al. for the European Cooperative Study Group. Retreatment with alteplase for early signs of reocclusion after thrombolysis. Am J Cardiol 1993;71:524-528.
34. 34. White HD, Cross DB, Williams BF, Morris RM. Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. Br Heart J 1990;64:177-181.
35. 35. White HD, Cross DB, Williams BF, et al. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. Am J Cardiol 1995;75:172-174.
36. 36. Madan M, Berkowitz SD, Tcheng JE. Glycoprotein IIb/IIIa Integrin blockade. Circulation 1998;98:2629-2635.
37. 37. Ohaman EM, Kleiman NS, Gacioch G, et al. for the IMPACT-AMI Investigators. Combined accelerated tissue plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction: results of a randomized, placebo-controlled, dose ranging trial. Circulation 1997;95:846-854.
38. 38. Antmann EM, Gugliano RP, Gibson CM, et al. for the TIMI 14 Investigators. Abciximab facilitates the rate and extent of thrombolysis: results of Thrombolysis In Myocardial Infarction (TIMI) 14 Trial. Circulation 1999;99:2710-2732.